序号 | 中文标题 | 英文标题 | 出处 | 月份 |
1 | 2024 专家建议:遗传性转甲状腺素蛋白淀粉样变性合并多发性神经病的诊断和治疗 | Diagnosis and treatment of hereditary transthyretin amyloidosis with polyneuropathy in the United States: Recommendations from a panel of experts | Muscle Nerve.2024 Jan 4. | 1月份 |
2 | 2023共识建议:多发性硬化的诊断和治疗 | Consensus recommendations for diagnosis and treatment of Multiple Sclerosis: 2023 revision of the MENACTRIMS guidelines | Mult Scler Relat Disord.2024 Jan 7:83:105435. | 1月份 |
3 | 脑小血管病MRI规范化应用专家共识 |
| 中华放射学杂志,2024,58(1):6-17. | 1月份 |
4 | 多发性硬化诊断与治疗中国指南(2023版) |
| 中华神经科杂志,2024,57(1):10-23. | 1月份 |
5 | 2024 AHA科学声明:脑静脉血栓形成的诊断和管理 | Diagnosis and Management of Cerebral Venous Thrombosis: A Scientific Statement From the American Heart Association | Stroke.2024 Jan 29. | 1月份 |
6 | 神经病理性疼痛评估与管理中国指南(2024 版) |
| 中国疼痛医学杂志,2024,30(1):5-14. | 2月份 |
7 | 2024 AHA科学声明:成人颈动脉夹层的治疗及预后 | Treatment and Outcomes of Cervical Artery Dissection in Adults: A Scientific Statement From the American Heart Association | Stroke.2024 Feb 1. | 2月份 |
8 | 抗癫痫发作药物联合使用中国专家共识 |
| 中华神经科杂志,2024,57(2):108-117. | 2月份 |
9 | 2024 BAN共识:5q脊髓性肌萎缩症的诊断、遗传咨询和疾病修饰治疗 | Consensus from the Brazilian Academy of Neurology for the diagnosis, genetic counseling, and use of disease-modifying therapies in 5q spinal muscular atrophy | Arq Neuropsiquiatr.2024 Jan;82(1):1-18. | 2月份 |
10 | 2024 ESO指南:脑小血管病—第2部分:腔隙性缺血性卒中 | European stroke organisation (ESO) guideline on cerebral small vessel disease, part 2, lacunar ischaemic stroke | Eur Stroke J.2024 Feb 21. | 2月份 |
11 | 2024 AHA科学声明:先天性心脏病患者的神经发育结局:神经保护、风险分层、评估和管理更新 | Neurodevelopmental Outcomes for Individuals With Congenital Heart Disease: Updates in Neuroprotection, Risk-Stratification, Evaluation, and Management: A Scientific Statement From the American Heart Association | Circulation.2024 Feb 22. | 2月份 |
12 | 2024 KNGF指南:腰痛和腰骶神经根综合征的管理 | Management of low back pain and lumbosacral radicular syndrome: the Guideline of the Royal Dutch Society for Physical Therapy (KNGF) | Eur J Phys Rehabil Med.2024 Feb 26. | 2月份 |